161 related articles for article (PubMed ID: 28451393)
1. The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.
Pendlebury A; Hannan NJ; Binder N; Beard S; Mcgauran M; Grant P; Tong S; Whitehead CL
Biomed Rep; 2017 Mar; 6(3):319-322. PubMed ID: 28451393
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
3. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
[TBL] [Abstract][Full Text] [Related]
4. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.
Cao Q; Lu K; Dai S; Hu Y; Fan W
Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949
[TBL] [Abstract][Full Text] [Related]
7. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
[TBL] [Abstract][Full Text] [Related]
8. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
[TBL] [Abstract][Full Text] [Related]
9. Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation.
Chen Y; Zhang L; Hao Q
Cancer Cell Int; 2013 Aug; 13(1):86. PubMed ID: 23978303
[TBL] [Abstract][Full Text] [Related]
10. Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas.
Kim S; Choi MC; Jeong JY; Hwang S; Jung SG; Joo WD; Park H; Song SH; Lee C; Kim TH; An HJ
J Cancer; 2019; 10(9):1958-1967. PubMed ID: 31205555
[No Abstract] [Full Text] [Related]
11. Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women.
Habel A; Nassar F; Itani M; Bouaziz H; Hadj-Ahmed M; Msheik Z; Stayoussef M; Nasr R; Yacoubi-Loueslati B
Afr Health Sci; 2023 Jun; 23(2):256-264. PubMed ID: 38223583
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer.
Hannan NJ; Cohen PA; Beard S; Bilic S; Zhang B; Tong S; Whitehead C; Hui L
Gynecol Oncol Rep; 2022 Feb; 39():100894. PubMed ID: 35005155
[TBL] [Abstract][Full Text] [Related]
13. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer.
Zhang B; Li Y; Li Y; Zhao H; An R
Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343
[TBL] [Abstract][Full Text] [Related]
14. Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.
Fitriawan AS; Kartika AI; Chasanah SN; Aryandono T; Haryana SM
Malays J Med Sci; 2020 Dec; 27(6):27-38. PubMed ID: 33447132
[TBL] [Abstract][Full Text] [Related]
15. Tissue and Circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c Reflects Disease Activity in Crohn's Disease Patients: Results from the BIOMIR Study.
Tocia C; Dumitru A; Mateescu B; Negreanu L; State M; Cozaru GC; Mitroi AF; Brinzan C; Popescu R; Leopa N; Iordache MM; Manea M; Matei E; Dumitru E; Alexandrescu L
J Gastrointestin Liver Dis; 2023 Mar; 32(1):30-38. PubMed ID: 37004230
[TBL] [Abstract][Full Text] [Related]
16. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Taylor DD; Gercel-Taylor C
Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer.
Gumusoglu-Acar E; Gunel T; Hosseini MK; Dogan B; Tekarslan EE; Gurdamar B; Cevik N; Sezerman U; Topuz S; Aydinli K
Oncol Lett; 2023 Apr; 25(4):142. PubMed ID: 36909377
[TBL] [Abstract][Full Text] [Related]
19. Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study.
Beilerli A; Begliarzade S; Sufianov A; Ilyasova T; Liang Y; Beylerli O
Noncoding RNA Res; 2022 Sep; 7(3):197-204. PubMed ID: 35991513
[TBL] [Abstract][Full Text] [Related]
20. miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases.
Liu J; Zhang X; Huang Y; Zhang Q; Zhou J; Zhang X; Wang X
Oncol Lett; 2019 Feb; 17(2):1453-1460. PubMed ID: 30675199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
